Howe Eloise Cutbush is helping develop new treatments at Addenbrooke’s
Hospital worker’s bid for glory
Ganesh Muthusamy tells of ongoing discrimination in India
Differences in most common causes of death in Cambridge, South Cambridgeshire and East Cambridgeshire emerge
Evonetix is a pioneer in the synthetic biology revolution
Epigenome research impacts our understanding of ageing, disease and the development of embryos
An award-nominated show garden will be recreated at Addenbrooke’s.
Steady decrease in smokers - but Cambridge still has more smokers than average for region
More than 50 patients on an average day remain in beds they no longer need at Cambridge University Hospitals.
Spray-on treatment is part of new approach to ageing
Machine learning and AI speed up research
Wellbeing divide haunts city: charity has vital role in challenging times
How the pitches went for eight life sciences incubator finalists
Life sciences conference proves of international value
A new £7m day-case unit including a state-of-the-art endoscopy suite has opened at Spire Cambridge Lea Hospital.
Cambridge Biomedical Campus company is part of international WINDOW Consortium working to defeat this deadly brain tumour
Averil Hart’s father tells Cambridgeshire health committee that his daughter’s death was “completely avoidable”
Women and children brave searing temperatures to take part in annual event
Founder and CEO outlines life science’s newest proprietary biotechnologies
Scientist is working at Cancer Research UK Cambridge Institute to find out what some patients fail to respond to treatments
Terrie lost her mum to bowel cancer - and is at increased risk of the disease herself
First start-up competition at Babraham includes Campus facilities as prize
To mark the NHS’s birthday, we’re looking at how Cambridge University Hospitals – incorporating Addenbrooke’s and The Rosie – developed over the decades.
Dr Mike Romanos, co-founder and chief executive, outlines the revelatory new discoveries.
The hospital was due to move to a new building on Cambridge Biomedical Campus in September.
£2.6m study could help reduce side effects for patients and save costs for the NHS
Parker’s Piece event for electric transport due on June 29 and 30
Microbiome’s IBD potential proves attractive to Roche’s Genentech
Aubrey de Grey is one of the world’s leading – and most talked-about – biomedical gerontologists
Study by Cancer Research UK Cambridge Institute finds it could halt tumour growth
Fluidic Analytics’s technology speeds up lab work – and is heading for the consumer care sector
Specialist Dementia nurse Jacqueline Young is aiming for more dementia awareness
Galaxy of Cambridge investors and healthcare firms stimulate radical advances
CEO Chris Torrance says it’s time for a shake-up in pharma model as Morningside joins investors
Helping biologists with ‘omics’ productivity
Founder/CEO of Washington-based Center for Advancing Innovation heads for Cambridge
£250,000 fundraising drive for perfusion machine at Cambridge hospital
An interview with CEO of pioneering Babraham Research Campus company
Babraham research firm has potential to slash drug discovery lead times
The idea of arts on prescription and social prescribing may seem like a new one, but it is actually more than 10 years since UK government policy first referenced linking patients with non-medical support in the community.
Find the perfect role for you – or advertise a vacancy
Find out more
Search for your next home – and read our sparkling content
Share your news, pictures and videos with us